ohdsi-studies/ScyllaCharacterization: Characterize all emerging drug therapies used in COVID-19 treatment
The aim of this study is to characterize all emerging drug therapies used in COVID-19 treatment. Specifically, the study aims to chararacterize: 1) Treatments administered during hospitalization and prior to intensive services, 2) Treatments administered during hospitalization after initiating intensive services, 3) Treatments administered after COVID-19 positive testing or diagnosis in outpatient setting without prior hospitalization.
Getting started
Browse package contents
Package details |
|
|---|---|
| Author | Anthony G. Sena [aut, cre] |
| Maintainer | Anthony G. Sena <asena5@its.jnj.com> |
| License | file LICENSE |
| Version | 1.0.1 |
| URL | https://github.com/ohdsi-studies/ScyllaCharacterization |
| Package repository | View on GitHub |
| Installation |
Install the latest version of this package by entering the following in R:
|
